The Group is a leading medical group in China specializing in the provision of hair medical services, providing one-stop hair care services, covering hair transplantation, medical maintenance, routine maintenance and other supporting services. Deeply involved in the hair care industry in China for decades, Yonghe Hair Transplant has become a well-known and trustworthy brand among hair transplant medical institutions in China. The Group has promoted many major developments in the industry and promoted the progress of the industry. Following the acquisition of Swanson's business in mainland China and successfully established the Swenson Medical Hair Center at its medical institutions in mainland China and the “independent store” models, the Group also acquired the Hong Kong business of prominent hair transplantation originating in the United States, a well-known hair transplant medical service provider, thereby further expanding its footprint beyond mainland China. Furthermore, through the joint construction of a joint hair laboratory with Peking University People's Hospital, the Group promotes research and promotion and application of standardized diagnosis and treatment procedures for alopecia diseases, and comprehensively promotes the hair medical service industry to a new stage of industry-university-research development. We believe these pioneering actions will enhance our core competencies and further strengthen our industry leadership position. The Group has established a one-stop medical care service system to meet the medical needs of a wide range of patients. With our standardized and highly scalable business model, the Group also has industry-leading operational capabilities, enabling us to effectively control costs, improve operational efficiency, and improve profitability. The Group continues to improve our R&D, diagnosis and treatment capabilities through cooperation with experts from the top three hospitals and well-known institutions. Furthermore, in order to continuously improve medical services for patients, gain a leading position in technology, and accelerate business development, the Group has been actively promoting the adoption of new technologies such as data application and analysis, artificial intelligence services, and online services in the business. We believe these advantages have strengthened our leading position in the industry and provided a continuing impetus for our future growth.
No Data